Epsilon Healthcare Limited (ASX:EPN) Update on Growth and Strategy
Epsilon Healthcare Limited (ASX:EPN) outlines its ambitious targets and operational capabilities, aiming for $14M revenue growth.
Tag: Corporate Strategy & Guidance
MetalsTech Limited (ASX:MTC) Announces Expiry of Royalty Payment Obligations
MetalsTech Limited (ASX:MTC) announces the expiry of its royalty payment obligations concerning the Sturec Gold Mine project.
Centrex Limited (ASX:CXM) Announces Voluntary Suspension
Centrex Limited (ASX:CXM) has suspended trading to finalize negotiations for capital raising and logistics agreements crucial for its financial stability.
TerraCom Limited (ASX:TER) Updates Moorlands Project Progress
TerraCom Limited (ASX:TER) updates on the Moorlands Project, outlining significant advancements and cooperative efforts with Wintime Energy Group.
Incitec Pivot Limited (ASX:IPL) Announces 2024 AGM Updates
Incitec Pivot Limited highlights its FY24 financial results and strategic initiatives during the 2024 AGM.
Midway Limited (ASX: MWY) Announces Court Approval for Scheme Meeting
Midway Limited (ASX: MWY) announces court approval for a scheme meeting regarding its acquisition by RCM BidCo.
Lycopodium Limited (ASX:LYL) Awarded Major Contracts for Koné Gold Project
Lycopodium Limited secures contracts for the Koné Gold Project, expected to produce 300,000 ounces of gold annually.
Sipa Resources Limited (ASX:SRI) Acquires New Gold Projects
Sipa Resources (ASX:SRI) expands its gold exploration portfolio through the acquisition of four advanced projects in SA and WA.
Sipa Resources Limited (ASX:SRI) Reinstatement to Quotation
Sipa Resources Limited (ASX:SRI) has had its trading suspension lifted following key announcements regarding an acquisition and capital raising.
Mesoblast Limited (ASX:MSB) Achieves FDA Approval for RYONCIL
Mesoblast Limited announces FDA approval of RYONCIL, the first MSC therapy for children with steroid-refractory acute graft versus host disease.